EP4304551A1 - Composition de soin bucco-dentaires - Google Patents

Composition de soin bucco-dentaires

Info

Publication number
EP4304551A1
EP4304551A1 EP22711558.1A EP22711558A EP4304551A1 EP 4304551 A1 EP4304551 A1 EP 4304551A1 EP 22711558 A EP22711558 A EP 22711558A EP 4304551 A1 EP4304551 A1 EP 4304551A1
Authority
EP
European Patent Office
Prior art keywords
chlorhexidine
composition
toothpaste
salt
oral care
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22711558.1A
Other languages
German (de)
English (en)
Inventor
Alison Katharine Green
Vera SLOMKA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever Global IP Ltd
Unilever IP Holdings BV
Original Assignee
Unilever Global IP Ltd
Unilever IP Holdings BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Global IP Ltd, Unilever IP Holdings BV filed Critical Unilever Global IP Ltd
Publication of EP4304551A1 publication Critical patent/EP4304551A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Definitions

  • the present invention is concerned with oral care compositions. More particularly, the present invention is concerned with oral care compositions containing chlorhexidine and its derivatives.
  • Chlorhexidine may be used in oral care compositions to exert beneficial physiological effects, such as prevention or amelioration of gingivitis or periodontitis, prevention and treatment of dental caries, periodontal disease, and other diseases of the oral cavity.
  • EP2100590 and EP185971 dislcoses oral care compositions comprising chlorohexiidine. And alkyl glucoside surfactants.
  • the effectiveness of chlorhexidine can be diminished by the presence of surfactants.
  • the present invention describes a combination of chlorhexidine and decyl glucoside which is particularly effective in suppressing the activity of microbes found in the oral cavity in a surfactant system.
  • the present invention provides an oral care composition a toothpaste composition comprising: a) silica based abrasive, b) chlorhexidine or chlorhexidine salt and c) a surfactant system comprising at least 50 wt% of decyl glucoside in which the weight ratio of chlorohexifine of cholohexidine salt to decyl glucoside is from 1 : 1 to 1:8
  • any upper value can be associated with any particular lower value.
  • a feature is disclosed with respect to a particular aspect of the invention (for example a composition of the invention), such disclosure is also to be considered to apply to any other aspect of the invention (for example a method of the invention) mutatis mutandis.
  • Dentifrice compositions according to the invention comprise chlorhexidine or chlorhexidine salt and decyl glucoside at a weight ratio of 1:1 to 1:8 of chlorhexidine salt to decyl glucoside.
  • the weight ratio of chlorhexidne salt to decyl glucoside is from 1 :2 to 1 :7. It is preferable if the chlorhexidine salt is chlorhexidine gluconate, chlorhexidine digluconate or mixtures thereof.
  • the chlorhexidine salt is chlorohexidine gluconate.
  • the chlorhexidine salt preferably present from 0.05 to 1 wt% of the total composition, more preferably from 0.1 wt% to 0.7 wt%.
  • the level of decyl glucoside is from 0.2 to 1.2 wt% of the total composition, more preferably from 0.5 to 0.9 wt%.
  • Decyl glucoside is present as at ease 50 wt% of the total surfactant present, preferably at least 75 wt%.
  • composition according to the invention will generally contain further ingredients to enhance performance and/or consumer acceptability, in addition to the ingredients specified above.
  • the composition comprises a silica based abrasive.
  • the preferred abrasive silicas used in the present invention is a silica with a low refractive index. It may be used as the sole abrasive silica, or in conjunction with a low level of other abrasive silicas, e.g. those according to EP 236070.
  • the low refractive index silicas, used as abrasives in the present invention are preferably silicas with an apparent refractive index (R.l.) in the range of 1.41 - 1.47, preferably 1.435 - 1.445, preferably having a weight mean particle size of between 5 and 15 mm, a BET (nitrogen) surface area of between 10 and 100 m 2 /g and an oil absorption of about 70 - 150 cm 3 /100 g, but abrasive silicas with a lower apparent refractive index may also be used.
  • suitable low refractive index abrasive silicas e.g. having an R.l.
  • silicas of between 1.435 and 1.445 are Tixosil 63 and 73 ex Rhone Poulenc; Sident 10 ex Degussa; Zeodent 113 ex Zeofinn; Zeodent 124 ex Huber, Sorbosil AC 77 ex Crosfield Chemicals (having an R. I . of approximately 1.440).
  • the amount of these silicas in the composition generally ranges from 5-60% by weight, usually 5-20% by weight the abrasive silica is present usually in amounts between 3 and 60% by weight of the oral care composition.
  • composition preferably comprises an inorganic or a natural or synthetic thickener or gelling agent in proportions of about 0.10 to about 15% by weight depending on the material chosen.
  • thickeners in the dentifrice compositions of the present invention form an extrudable, shape-retaining product which can be squeezed from a tube onto a toothbrush and will not fall between the bristles of the brush but rather, will substantially maintain its shape thereon.
  • Suitable thickeners or gelling agents useful in the practice of the present invention include inorganic thickening silicas such as amorphous silicas available from Huber Corporation under the trade designation Zeodent 165, Sident225, Irish moss, iota-carrageenan, gum tragacanth, and polyvinylpyrrolidone.
  • compositions according to the invention preferably comprise a polymeric deposition aid.
  • the composition comprises acid anhydride polymers, particularly preferred are co-polymers of maleic anhydride with methyl vinylether, in which the anhydride moiety may be in a partially or fully hydrolysed or alcoholysed form.
  • Preferred copolymers include Gantrez(R) polymers such as: Gantrez S-95: molecular weight 216,000; free acid;
  • Gantrez S-96 molecular weight 700,000; free acid
  • Gantrez S-97 molecular weight 1 ,500,000; free acid; and Gantrez MS-955: molecular weight 1,060,000; calcium/sodium salt.
  • Particularly preferred co-polymers of maleic acid and methyl vinylether have a molecular weight of 1 ,000,000 or greater and an especially preferred material is Gantrez S-97.
  • compositions according to the invention may comprise a tooth whitening agent.
  • the whitening agent preferably comprises a green and/or a blue pigment.
  • a pigment is generally understood to be a shade/material which is insoluble in the relevant medium, at the relevant temperature. This is in contrast to dyes which are soluble.
  • the "relevant medium” is human saliva, the liquid medium in which the composition is used, at the temperature of the oral cavity during brushing of the teeth, i.e. up to 37 Degrees C. As a reasonable approximation, the relevant medium may be considered to be water and the relevant temperature to be 25 Degrees C.
  • the blue pigment is Pigment Blue 15, more preferably Pigment Blue 15:1 , 15:2, 15:3,
  • a preferred pigment is blue pigment is Phthalocyanine Blue Pigment, Cl No. 74160, blue covarine.
  • the preferred Green pigment is Phthalocyanine Green, preferably Phthalocyanine Green CI-74260.
  • the total level of pigment in the composition is from 0.01 wt% to 3 wt, more preferably from 0.02 to 2 wt%.
  • composition is a toothpaste it may be a dual phase paste, with the whitening pigments present in one phase.
  • compositions according to the invention may comprise water-soluble or sparingly water-soluble sources of metal salts
  • zinc ions such as zinc chloride, zinc acetate, zinc gluconate, zinc sulphate, zinc fluoride, zinc citrate, zinc lactate, zinc oxide, zinc monoglycerolate, zinc tartrate, zinc pyrophosphate and zinc maleate
  • stannous ions such as stannous fluoride and stannous chloride.
  • compositions according to the invention may comprise oral care enzyme systems such as hydrogen peroxide producing enzyme systems (e.g. the oxidoreductase enzyme glucose oxidase), amyloglucosidase, dextranase and/or mutanase, (optionally in the presence of zinc ion providing compounds and/or 8- hydroxyquinoline derivatives), lactoperoxidase, lactoferrin, lysozyme and mixtures thereof.
  • hydrogen peroxide producing enzyme systems e.g. the oxidoreductase enzyme glucose oxidase
  • amyloglucosidase e.g. the oxidoreductase enzyme glucose oxidase
  • dextranase and/or mutanase e.g. the oxidoreductase enzyme glucose oxidase
  • mutanase e.g. the mutanase
  • lactoperoxidase e.g. the
  • Compositions of the invention may comprise fluoride sources such as sodium fluoride, stannous fluoride, sodium monofluorophosphate, zinc ammonium fluoride, tin ammonium fluoride, calcium fluoride, cobalt ammonium fluoride and mixtures thereof.
  • fluoride sources such as sodium fluoride, stannous fluoride, sodium monofluorophosphate, zinc ammonium fluoride, tin ammonium fluoride, calcium fluoride, cobalt ammonium fluoride and mixtures thereof.
  • a preferred class of oral care active for inclusion in the compositions of the invention includes agents for the remineralisation of teeth.
  • remineralisation in the context of the present invention means the in situ generation of hydroxyapatite on teeth.
  • composition according to the invention will comprise further ingredients which are common in the art, such as:
  • antimicrobial agents e.g. sanguinarine extract, metronidazole, quaternary ammonium compounds, such as cetylpyridinium chloride; hexetidine, octenidine, alexidine; and halogenated bisphenolic compounds, such as 2,2' methylenebis-(4-chloro-6-bromophenol); anti-inflammatory agents such as ibuprofen, flurbiprofen, aspirin, indomethacin etc.; anti-caries agents such as sodium- and stannous fluoride, aminefluorides, sodium monofluorophosphate, sodium trimeta phosphate and casein; plaque buffers such as urea, calcium lactate, calcium glycerophosphate and strontium polyacrylates; vitamins such as Vitamins A, C and E; plant extracts; plant-derivable antioxidants such as flavonoid, catechin, polyphenol, and tannin compounds and mixtures thereof; desensitising agents, e.g.
  • starch starch, sucrose, water or water/alcohol systems etc.
  • surfactants such as anionic, nonionic, cationic and zwitterionic or amphoteric surfactants
  • Humectants such as glycerol, sorbitol, propyleneglycol, xylitol, lactitol etc.
  • binders and thickeners such as sodium carboxymethyl-cellulose, hydroxyethyl cellulose (Natrosol®), xanthan gum, gum arabic etc.
  • bleaching agents such as peroxy compounds e.g. potassium peroxydiphosphate, effervescing systems such as sodium bicarbonate/citric acid systems, colour change systems, and so on.
  • Bacterial membrane integrity measured as membrane polarity and permeability, is an indicator of cell viability.
  • Chlorhexidine digluconate (CHX) as a cationic is proposed to damage the integrity of the bacterial cell walls and reduce viability.
  • DiBAC 4 (Bis-(1,3-Dibutylbarbituric Acid), a commercially available fluorescence probe, can enter depolarized cells where it binds to intracellular proteins or membrane and exhibits enhanced fluorescence and a red spectral shift. Increased depolarization results in additional influx of the anionic dye and an increase in fluorescence, indicating damaged bacteria and reduced viability. Protocol.
  • toothpaste slurries were prepared as 1 : 10 dilutions in sterile de-ionised water

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une composition de dentifrice comprenant : a) un abrasif à base de silice, b) de la chlorhexidine ou un sel de chlorhexidine; c) un système tensioactif comprenant au moins 50 % en poids de décyl-glucoside dans lequel le rapport pondéral de la chlorhexidine ou du sel de chlorhexidine au décyl-glucoside est de 1 : 1 à 1 : 8.
EP22711558.1A 2021-03-11 2022-03-10 Composition de soin bucco-dentaires Pending EP4304551A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21162078 2021-03-11
PCT/EP2022/056276 WO2022189604A1 (fr) 2021-03-11 2022-03-10 Composition de soin bucco-dentaires

Publications (1)

Publication Number Publication Date
EP4304551A1 true EP4304551A1 (fr) 2024-01-17

Family

ID=74871282

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22711558.1A Pending EP4304551A1 (fr) 2021-03-11 2022-03-10 Composition de soin bucco-dentaires

Country Status (5)

Country Link
EP (1) EP4304551A1 (fr)
CN (1) CN116981440A (fr)
BR (1) BR112023014904A2 (fr)
CL (1) CL2023002661A1 (fr)
WO (1) WO2022189604A1 (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3444958A1 (de) 1984-12-10 1986-06-12 Henkel KGaA, 4000 Düsseldorf Verwendung von alkylglykosiden als potenzierungsmittel in antiseptischen mitteln sowie desinfektions- und reinigungsmittel mit verstaerkter bakterizider wirkung
GB8604985D0 (en) 1986-02-28 1986-04-09 Unilever Plc Precipitated silicas
JPH09510192A (ja) * 1994-02-24 1997-10-14 リングナー＋フィッシャー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 透明液体歯磨剤
DE4406748A1 (de) * 1994-03-02 1995-09-07 Henkel Kgaa Mund- und Zahnpflegemittel
JP2004026724A (ja) * 2002-06-26 2004-01-29 Sunstar Inc 口腔用組成物
CN101563064A (zh) 2006-11-14 2009-10-21 新时代株式会社 含有用水溶性物质进行了表面处理的结晶纤维素的口腔用组合物

Also Published As

Publication number Publication date
WO2022189604A1 (fr) 2022-09-15
CN116981440A (zh) 2023-10-31
BR112023014904A2 (pt) 2023-10-31
CL2023002661A1 (es) 2024-05-17

Similar Documents

Publication Publication Date Title
US20020122776A1 (en) Oral bleaching composition
CA2303370C (fr) Dentifrices a efficacite amelioree contenant du fluorure et du glycomacropeptide de caseine
AU2016371133B2 (en) Oral care compositions comprising at least one phosphate/acrylate copolymer and at least one cationic active ingredient
WO2023094383A1 (fr) Composition de soin buccal comprenant un matériau composite bipolaire
WO2022189604A1 (fr) Composition de soin bucco-dentaires
EP3955883B1 (fr) Composition de soins personnels comprenant de la tétraméthylcurcumine et son procédé de production
EP3955884B1 (fr) Composition de soins personnels comprenant de la piperlongumine et son procédé de production
EP3952829B1 (fr) Procédé de préparation d'une composition de soins bucco-dentaires comprenant du gingerdiol
WO2023227282A1 (fr) Composition de soin buccal
WO2023247291A1 (fr) Composition de soin buccodentaire pour atténuer et/ou inverser l'érosion de l'émail dentaire provoquée par le port d'un aligneur
WO2023247292A1 (fr) Composition de soin buccal atténuer et/ou réparer l'érosion de l'émail dentaire provoquée par le port d'un aligneur
WO2023138996A1 (fr) Composition de soin buccodentaire
RU2801309C2 (ru) Композиция для ухода за полостью рта
EP4037641B1 (fr) Composition de soin oral comprenant de l' hexametaphosphate et un pigment
WO2023138811A1 (fr) Composition de soin buccal
WO2023186746A1 (fr) Composition de soin buccodentaire
WO2023186648A1 (fr) Composition de soin buccodentaire
WO2023247290A1 (fr) Composition de soin buccodentaire pour atténuer et/ou inverser l'érosion de l'émail dentaire provoquée par l'usure d'un aligneur
WO2023186583A1 (fr) Composition de soin buccodentaire
CN118632678A (zh) 口腔护理组合物
WO2023213460A1 (fr) Composition de soin buccodentaire
WO2024104743A1 (fr) Composition de soins buccodentaires
WO2023152198A1 (fr) Utilisation d'une composition pour soin buccal
EP4331562A1 (fr) Utilisation de composition de protection orale
EP4417182A1 (fr) Composition de soin buccal

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230714

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS